Multidisciplinary management of locoregional breast cancer recurrence

Liz Meszaros, MDLinx

San Antonio Breast Cancer Symposium 2017

San Antonio, Texas, United States | December 05-09, 2017

Locoregional recurrences of breast cancers are rare, but when they do occur, can be challenging and typically require a multidisciplinary evaluation.

As far as evaluating treatment approach, surgery should be the first option considered.

"As we've had more effective therapies, both surgically and systemically, the frequency of actually developing either local, in-breast recurrences or the more troubling other locoregional recurrences such as in lymph nodes has become progressively less common," said William Gradishar, MD, professor of medicine, Northwestern University, Evanston, IL.

He outlined some of the management and treatment considerations in these cases.

All Interviews

From this Conference

2:14

Breast cancer: Where we were and how far we’ve come
Over the past few decades, great progress has been made in the field of breast cancer, according to Tatiana Prowell, MD, breast cancer scientific liaison, FDA Oncology Center...
Tatiana Prowell, MD
1:47

Evaluating the risk of breast cancer among female patients
There are several factors that put female patients at an increased risk for breast cancer.
Amy C. Degnim, MD
2:34

Are clinical trials representative of a broader patient population?
In clinical trials for cancer drug development, researchers have been enrolling patients who are otherwise healthy; patients who are asymptomatic, and have free mobility. By...
Tatiana Prowell, MD

1:11

Breast imaging can predict cancer recurrence
At the 2018 Best of SABCS-NY, Sheldon Feldman, MD, FACS, chief of breast surgery and breast surgical oncology, Montefiore-Einstein Cancer Center, New York, director of breast...
Sheldon Feldman, MD, FACS
0:52

Value of chemotherapy for patients with locoregional breast cancer recurrence
Although chemotherapy can positively impact patient outcomes after locoregional recurrence of breast cancer, this will generally occur only in patients with HR-negative (HR-)...
William Gradishar, MD
1:15

The paradoxical role of family history in breast cancer risk
Although family history can influence a patient’s risk of developing breast cancer, it does not increase that risk once other risk factors are identified.
Amy C. Degnim, MD

This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium 2017.